View Older Stories View More Recent Stories

Jun 15, 2022 07:00AM PolyPid Hosting Key Opinion Leader Webinar on Managing the Cost of Surgical Site Infections
Jun 6, 2022 07:00AM PolyPid Announces Presentation of D-PLEX₁₀₀ Phase 2 Clinical Data at ASM Microbe 2022
Jun 2, 2022 07:00AM PolyPid to Present at the JMP Securities 2022 Life Sciences Conference
Jun 1, 2022 07:00AM PolyPid Announces Publication of Animal Model Studies in 2022 ASCO Annual Meeting Abstract Demonstrating that Locally Administered OncoPLEX Potentially Decreases the Likelihood of Tumor Recurrence wit
May 31, 2022 07:04AM PolyPid Ltd. (PYPD) Completes Enrollment of SHIELD I Phase 3 Study of D-PLEX100
May 31, 2022 07:00AM PolyPid Announces Completion of Enrollment in Phase 3 SHIELD I Trial of D-PLEX₁₀₀ for Prevention of Surgical Site Infections in Abdominal Surgery
May 23, 2022 07:03AM PolyPid Ltd. (PYPD) Reports Data Safety Monitoring Board Recommended to Conclude Enrollment of Phase 3 SHIELD I Trial of D-PLEX at the Minimum Number of Patients Targeted
May 23, 2022 07:00AM PolyPid Announces Recommendation by Data Safety Monitoring Board to Conclude Enrollment of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ at the Minimum Number of Patients Targeted Following Unblinded Inte
May 11, 2022 07:00AM PolyPid Provides Corporate Update and Reports First Quarter 2022 Financial Results
Apr 27, 2022 07:00AM PolyPid to Report First Quarter 2022 Financial Results and Operational Highlights on May 11, 2022
Apr 25, 2022 07:30AM PolyPid Announces Presentation at the 13th European and Global CLINAM Summit for Nanomedicine
Apr 12, 2022 08:00AM PolyPid Announces Presentation of Clinical Data at Surgical Infection Society 2022 Annual Meeting
Apr 6, 2022 07:03AM PolyPid Ltd. (PYPD) Announces $15M Non-Dilutive Secured Term Loan Facility with Kreos Capital VI
Apr 6, 2022 07:00AM PolyPid Secures $15 Million Non-Dilutive Secured Term Loan Facility
Mar 8, 2022 07:00AM PolyPid to Deliver Poster Presentation at SAGES 2022
Mar 2, 2022 07:00AM PolyPid Announces 750th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ in Abdominal Surgery
Mar 1, 2022 07:00AM PolyPid to Present at the Barclays Global Healthcare Conference
Feb 9, 2022 07:00AM PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
Jan 26, 2022 07:30AM PolyPid to Report Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 9, 2022
Jan 4, 2022 07:30AM PolyPid Appoints UCSF Brain Tumor Center Director Mitchel S. Berger, M.D., to Oncology Advisory Board
Jan 3, 2022 07:30AM PolyPid Ltd. (PYPD) Announces Upcoming CEO Transition
Jan 3, 2022 07:30AM PolyPid Announces Planned CEO Transition
Nov 18, 2021 07:00AM PolyPid Announces 500th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ in Abdominal Surgery
Nov 16, 2021 07:00AM PolyPid Appoints New Oncology Advisory Board Member
Nov 10, 2021 07:00AM PolyPid Ltd. Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Nov 1, 2021 07:00AM PolyPid to Report Third Quarter 2021 Financial Results and Operational Highlights on November 10, 2021
Sep 20, 2021 07:00AM PolyPid to Present at Upcoming Cantor Fitzgerald Global Healthcare Conference
Sep 13, 2021 07:33AM PolyPid (PYPD) Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
Sep 13, 2021 07:30AM PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
Aug 17, 2021 08:00AM PolyPid to Present at First World Association Against Infection in Orthopaedics and Trauma Congress
Aug 11, 2021 07:00AM PolyPid Ltd. Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Aug 9, 2021 08:00AM PolyPid to Present at the Investor Summit Virtual Conference on August 18, 2021
Jul 28, 2021 07:00AM PolyPid to Report Second Quarter 2021 Financial Results and Operational Highlights on August 11, 2021
Jul 12, 2021 08:00AM PolyPid Strengthens Executive Team, Appointing Dr. Anthony Senagore as Senior Medical Director
Jun 23, 2021 06:30AM PolyPid Presents today at The Raymond James Human Health Innovation Conference
Jun 2, 2021 09:10AM PolyPid to Present at Upcoming Healthcare Investor Conferences
May 19, 2021 08:02AM PolyPid Ltd. (PYPD) Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ Development Program
May 19, 2021 08:00AM PolyPid Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ Development Program
May 12, 2021 07:00AM PolyPid Ltd. Reports First Quarter 2021 Financial Results and Provides Corporate Update
Apr 29, 2021 07:00AM PolyPid to Report First Quarter 2021 Financial Results and Operational Highlights on May 12, 2021
Feb 23, 2021 07:30AM PolyPid to Participate in Upcoming Investor Conferences
Feb 16, 2021 07:30AM PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections
Feb 10, 2021 07:00AM PolyPid Ltd. Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
Jan 27, 2021 07:30AM PolyPid to Report Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights on February 10, 2021
View More Recent Stories View Older Stories